CGX Chromogenex

0.325

0.00 (0.00%)

25 Jun 2024 - Closed

Delayed by 15 minutes

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Chromogenex	LSE:CGX	London	Ordinary Share	GB00B0B7XX32	ORD 1P

	Price Change	% Change	Share Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Shares Traded	Last Trade
	0.00	0.00%	0.325						0.00	01:00:00

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
	0	0		N/A	0

Canadian Health Approval

14/04/2008 8:01am

UK Regulatory

RNS Number:2189S
Chromogenex PLC
14 April 2008

                           
                                      
                                Chromogenex plc
                                 (the 'Company)

                            Canadian Health Approval


Further to the announcement made on the 25 January 2008, the Company is pleased
to announce that it has now received the required medical device licence from
the Canadian Health Authority for the Chromolite-S allowing the Company to sell
this product in Canada.

Having taken immediate action to remedy the situation, the Board expects the 
deferred sales now to contribute to the financial year ending 31 December 2008.

In addition, the Company anticipates positive news on its Nlite application in 
the near future and will update the market in due course.




                                    - ends -



Chromogenex PLC                                        Tel: +44 20 8434 0540
Peter McGuinness, Chairman

HB Corporate
Luke Cairns                                            Tel: +44 (0)20 7510 8600

Threadneedle Communications
Graham Herring/Alex White                              Tel: +44 (0)20 7936 9605





                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
MSCEAXLFFENPEFE